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Abstract
In our previous study, we have shown that berberine has both anti-adipogenic and anti-inflammatory effects on 3T3-L1 adipocytes, and the anti-adipogenic
effect is due to the down-regulation of adipogenic enzymes and transcription factors. Here we focused more on anti-inflammatory effect of berberine
using real time RT-PCR and found it changes expressions of adipokines. We hypothesized that anti-adipogenicity of berberine mediates anti-inflammtory
effect and explored leptin as a candidate mediator of this signaling. We studied this hypothesis by western blot analysis, but our results showed
that berberine has no effect on the phosphorylations of STAT-3 and ERK which have important roles on leptin signaling. These results led us
to conclude that the anti-inflammatory effect of berberine is not mediated by the inhibition of leptin signal transduction. Moreover, we have found
that berberine down-regulates NF-κB signaling, one of the inflammation-related signaling pathway, through western blot analysis. Taken together,
the anti-inflammatory effect of berberine is not mediated by leptin, and berberine induces anti-inflammatory effect independent of leptin signaling.
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Introduction2)
Berberine is an isoquinoline derivative alkaloid isolated from 
many medicinal herbs, such as Hydrastis Canadensis (goldenseal), 
Cortex phellodendri (Huangbai) and Rhizoma coptidis (Huanglian) 
(Ikram, 1975). Several studies have shown that berberine has 
many pharmacological effects including inhibition of adipocyte 
differentiation, LDL-lowering effects and anti-inflammatory 
potential (Choi et al., 2006; Kong, 2004; Kuo et al., 2004). 
However, the anti-adipogenic and anti-inflammatory mechanism 
of berberine has not been elucidated clearly yet.
Recently, the evidence from many studies indicates that obesity 
is closely related with inflammation (Fantuzzi, 2005). Adipocytes 
actually secrete many inflammatory molecules such as leptin, 
TNF-α, PGE2, adiponectin, etc. (Hotamisligil et al., 1993; 
Trayhurn & Wood, 2004). Especially, the role of leptin in 
inflammation has become increasingly evident and has been 
reviewed recently (La Cava & Matarese, 2004). Not only leptin 
has structural and functional similarity to other pro-inflammatory 
cytokines such as TNF-α  and IL-6, but also its signaling is 
accelerated by pro-inflammatory cytokines (Baumann et al., 
1996; Otero et al., 2006). The binding of leptin to leptin receptor 
results in the activation of JAK-2 and leads to the phosphorylation 
of cytoplasmic target proteins, including STAT-3 and the MAPK 
(Lam & Lu, 2007). As with leptin, adiponectin is produced 
mainly by adipocytes. However, in contrast to leptin, adiponectin 
is considered to be an anti-inflammatory cytokine and has 
anti-inflammatory effects in various animal models of liver 
inflammation (Bastard et al., 2006). 
Some research groups are making their efforts on elucidating 
the anti-adipogenic and anti-inflammatory effects of berberine 
(Enk  et al., 2007; Hu et al., 2008; Kim et al., 2008; Kuo et 
al., 2004), although how berberine makes these two effects is 
not elucidated yet. Previously, we reported that berberine has 
an anti-adipogenic effect by reducing the expression of 
adipogenic transcription factors and the mRNA expressions of 
inflammatory molecules (Choi et al., 2006). This result led us 
to hypothesize that leptin, which is dominantly synthesized in 
adipocytes and related with inflammation, is the molecule that 
mediates the anti-inflammatory effects of berberine in adipocytes. 
In other words, berberine reduces fat accumulation and further 
down-regulates leptin synthesis, so the decrease of leptin 
signaling in an autocrine way might be in charge of the reduction 
of inflammatory molecule expressions.
Therefore, in this study, we examined the effect of berberine 
in mRNA expressions of adipokines by real-time RT-PCR. Then 
we investigated whether the reduced expressions of inflammatory 
molecules by berberine are due to the down-regulation of leptin 
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signaling. For this purpose, we examined the change of leptin 
signaling especially STAT-3 and ERK phosphorylations by 
berberine, by western blot analysis. Furthermore, we examined 
I-κB phosphorylation in order to investigate NF-κB signaling.
Materials and Methods
Materials
High-glucose DMEM, BCS, and FBS were purchased from 
Hyclon (Logan, Utah, USA). Trypsin/EDTA, insulin, dexamethasone, 
IBMX, and MTT which is used in cell culture and sample treatment 
were purchased from Sigma (St. Louis, MO, USA). 
Trizol for RNA extraction was purchased from Invitrogen 
(Carlsbad, CA, USA), Superscript II reverse transcriptase was 
purchased from BD Bioscience (San Jose, CA, USA), 2 X SYBR 
green Mix was purchased from ABI Applied Bioscience (Foster 
City, CA, USA) and all primers and oligo dT primer were 
purchased from Bioneer (Daejeon, Korea). 
Antibody against ERK1/2, phosphor-ERK1/2, β-actin, anti-rabbit 
IgG-horseradish peroxidase-conjugated, anti-mouse IgG-horseradish 
peroxidase-conjugated were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA, USA). Anti-STAT3 and anti- 
phospho-STAT3 antibodies were purchased from Biosource 
(Camarillo, CA, USA) and anti-IκB and anti-phospho-IκB were 
from Cell Signaling (Danvers, MA, USA).
3T3-L1 adipocytes culture and treatment of sample
Mouse 3T3-L1 pre-adipocytes were grown to confluence in 
DMEM with 10% BCS at 37℃ in a humidified atmosphere of 
5% CO2. At 1 day post-confluence (designated “day 0”), cell 
differentiation was induced with a mixture of methylisobutylxanthine 
(0.5 mM), dexamethasone (0.25 mM), and insulin (5 mg/ml) in 
DMEM containing 10% FBS. On day 2 and thereafter, DMEM 
containing 10% FBS and insulin (5 mg/ml) only was subsequently 
replaced every 2 days.
Berberine was dissolved in DMSO, divided into small 
quantities, and stored in -20℃. At day 8, after inducing 
differentiation of adipocytes, the sample was dissolved in DMEM 
at 10 mM concentration, which was treated into adipocytes for 
4 hours. The final concentration of DMSO was less than 0.1%. 
After treating the samples for 4 hours, cells were used for RNA 
extraction, as described below.
RNA extraction and cDNA synthesis
Total RNA was isolated from 3T3-L1 adipocytes using Trizol 
reagent. First strand cDNA synthesis was performed with 2 mg 
of total RNA using Superscript II reverse transcriptase (BD 
bioscience, Palo Alto, CA, USA).
Real-time RT-PCR
Real-time RT-PCR analysis was performed by Applied 
Biosystems 7500 Real Time PCR system (Applied Biosystems, 
Foster City, CA, USA). Samples (mixture that 2 X SYBR green 
Mix, 0.5 μM each appropriate primers, and cDNA) were 
incubated in the Applied Biosystems 7500 Real Time PCR 
system for an initial denaturation at 94℃ for 10 min, followed 
by 40 PCR cycles. Each cycle consisted of 95℃ for 15s, 60℃ 
for 1minute. To confirm amplification of specific transcripts, 
melting curve profiles (cooling the sample to 65℃ for 15s and 
heating slowly to 95℃  with continuous measurement of 
fluorescence) were produced at the end of each PCR. The 
oligonucleotide primers for the experiments are: beta-actin; 
5’-AGCCATGTACGTAGCCATCC-3’ and 5’-TCCCTCTCAGC
TGTGGTGAA-3’, leptin; 5’-AGGATCTGAGGGGTGATGTGA
-3’ and 5’-TGAGGTGACCAAGGTGGCATAG-3’, MCP-1; 5’-T
TAAAAACCTGGATC GGAACCAA-3’ and 5’-GCATTAGCTT
CAGATTTACGGGT-3’, adiponectin; 5’-GTC TCAGCTGTCG
GTCTTCCCCT-3’ and 5’-CCCTGGCTTTATGCTCTT TGC-3’.
Western blot analysis
After experimental treatment, cells were washed twice with 
ice-cold phosphate-buffered saline and lysed with extraction 
buffer (containing 50 mM Tris-HCl, pH 7.5), 150 mM NaCl, 
1% NP-40, 1 mM EDTA, 10 mM sodium pyrophosphate, 1 mM 
sodium orthovanadate, 100 mM NaF, 1 mM PMSF and protease 
inhibitor cocktail on ice for 30 min. Insoluble materials were 
removed by centrifugation at 15,000g for 10 min at 4℃. The 
total concentration of extracted proteins was determined using 
the method of Bradford. The proteins in the supernatants were 
separated by 10% SDS-PAGE and transferred into nitrocellulose 
membranes. After blocking with TBS-T (10 mM Tris, 150 mM 
NaCl, 0.05% Tween-20, pH 7.6) containing 5% nonfat milk for 
1 h at room temperature, the membranes were incubated with 
the appropriate first antibodies. To detect the antigen-bound 
antibodies, the blots were treated with secondary antibodies 
conjugated with horseradish-peroxidase. Immuno-reactivity was 
detected by using the ECL Western blotting detection system.
Statistical analysis
The data was analyzed by the ANOVA procedure of Statistical 
Analysis System (SAS Institute, 1999-2001). Significant differences 
between groups were determined using Duncan’s multiple range 
tests at the p<0.05 level.
Results
The anti-inflammatory effect of berberine
Previously, we showed that the mRNA expressions of 86 Leptin and anti-inflammatory effect of berberine
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Fig. 1. mRNA expressions of adipokines in BBR-treated 3T3-L1 adipocytes. At 
day 7 after inducing differentiation, adipocytes were cultured in 6-well plates with 
or without BBR for 18 hours. (a) Graph reporesents mRNA expressions of adipokines 
such  as  leptin,  MCP-1,  and  adiponectin.  Time  course  treatment  berberine  was 
conducted for 1 hour, 2 hours, 4 hours, 6 hours, 12 hours, and 24 hours. Graphs 
r e p r e s e n t  m R N A  e x p r e s s i o n s  o f  ( b )  T N F - α  a n d  ( c )  l e p t i n .  ( * p <0.05,  **p<0.01, 
***p<0.001)  Data  are  expressed  relative  to  untreated  control  cells  and  represent 
means ± S.E.  Experiments  were  conducted  twice,  each  included  triplication. 
(a)
(b)
Fig. 2. Leptin signaling in BBR-treated 3T3-L1 adipocytes. At day 8 after inducing 
differentiation, adipocytes were cultured in 6-well plates with or without BBR for 4 
hours. Graphs represent (a) phosphorylation of STAT-3 and (b) phosphorylation of 
ERK.  Experiments  were  conducted  twice,  each  included  triplication. 
inflammatory molecules such as TNF-α, IL-6, CRP, and 
Haptoglobin are decreased by berberine treatment in 3T3-L1 
adipocytes. Here we focused more on adipokines and studied 
how their mRNA expressions are influenced by berberine 
treatment. We treated berberine for 18 hrs on fully differentiated 
adipocytes and examined mRNA expression levels of leptin, 
adiponectin, and MCP-1. Leptin and MCP-1 mRNA expressions 
were greatly decreased about 80-90%, but adiponectin which has 
a special role in anti-inflammation was increased by 35% after 
treatment of berberine (Fig. 1-a). In order to investigate when 
the inflammatory molecules are reduced mostly after a treatment 
of berberine, we examined the time course of TNF-α and leptin 
mRNA expressions in berberine-treated 3T3-L1 adipocytes. The 
mRNA expressions of TNF-α and leptin were estimated by real 
time RT-PCR. The mRNA expression of TNF-α was decreased 
mostly 4 hours later, then increased by 6 hours of treatment and 
went back to the original level of expression at 24 hours of 
treatment (Fig. 1-b). The mRNA expression of leptin was 
decreased more than 40% during all the times of berberine 
treatment (Fig. 1-c). Therefore, we chose 4 hours berberine- 
treated samples for the further investigations. 
The anti-inflammatory effect of berberine is not mediated by 
leptin signaling
Anti-adipogenic and anti-inflammatory effects of berberine 
were shown in Fig. 1 and our previous report (Choi et al., 2006). 
Through these data, we assumed that reduced adipogenisity by 
berberine induces down-regulation of inflammatory molecules. Bong-Hyuk Choi et al. 87
Fig. 3. The change of NF-κB signaling in 3T3-L1 adipocytes by BBR treatment. 
At day 8 after inducing differentiation, adipocytes were cultured in 6-well plates with 
or without BBR for 4 hours. Graphs represent phosphorylation of I-κB. Experiments 
were  conducted  twice,  each  included  triplication.
We chose the leptin signaling as the best candidate to explore 
and have examined the effect of berberine on STAT-3 
phosphorylation and ERK phosphorylation. STAT-3 and ERK 
phosphorylations were measured by western blotting and STAT-3 
and ERK were used as internal control, respectively. However, 
contrary to our expectation, the phosphorylations of STAT-3 and 
ERK were not significantly changed after berberine treatment. 
(Fig. 2-a, b). 
The phosphorylation level of I-κB is decreased by berberine 
treatment
According to the previous experiments, berberine does not 
seem to inhibit the leptin signaling pathway. Therefore, we 
investigated the anti-inflammatory effect of berberine itself 
instead of examining berberine’s anti-inflammatory effect in 
accordance with its anti-adipogenic effect. In this regard, we have 
investigated the activity of NF-κB which is the representative 
transcription factor of inflammation. Inactive NF-κB exists as 
a dimer with I-κB and along with the I-κB phosphorylation, NF-κ
B becomes activated (Ghosh et al., 1998). So we have examined 
the changes in I-κB phosphorylation by berberine in 3T3-L1 
adipocytes. And we have found approximately a 57% decrease 
of I-κB phosphorylation (Fig. 3).
Discussion
In this study, we have shown that berberine reduces the 
expression of leading adipokines such as leptin and MCP-1 and 
increases adiponectin expression. Berberine mostly reduces TNF-
α and leptin expression levels at 4 hours of treatment. However, 
berberine does not have an effect on phosphorylation of STAT-3 
or ERK, key proteins of leptin signaling. Berberine has a reducing 
effect on I-κB phophorylation which is in charge of NF-κB 
activation.
In our previous report, we have shown that berberine reduces 
the expression levels of 3T3-L1 adipocyte-secreted inflammatory 
molecules (Choi et al., 2006). Here we focused more on key 
adipokines and found berberine has an anti-inflammation effect 
on adipocytes. Then we were intrigued to know about the most 
effective time of berberine treatment and examined the 
expression of TNF-α and leptin in a time-dependent manner. 
TNF-α  expression was the lowest and leptin expression was 
mostly down-regulated on two to four hours of berberine 
treatment. Through this, our group hypothesized that the 
anti-inflammatory effect of berberine might be mediated by 
leptin. In other words, the decrease of adipocyte differentiation 
by berberine treatment results in the decrease of leptin secretion, 
so that leptin-induced inflammation is diminished and finally the 
expressions of inflammatory molecules are declined. 
In this regard, we examined that the phosphorylation of 
STAT-3 which has a critical role in leptin receptor signaling. 
To our surprise, the phosphorylation level of STAT-3 in the 
berberine-treated sample was almost the same as the control. We 
also explored on activation of ERK by berberine, another key 
pathway in leptin signaling. However, ERK phosphorylation was 
not affected by berberine treatment as well. In addition, the levels 
of STAT-3 phosphorylation and ERK phosphorylation were not 
changed by leptin treatment as well. According to Machinal- 
Quélin, leptin has proadipogenic effect on preadipocytes by 
activating STAT-3 and MAPK signaling pathways but on 
differentiated adipocytes, leptin has no effect on both signaling 
pathways (Machinal-Quélin et al., 2002). 
From these results, we concluded that berberine does not inhibit 
leptin signaling. So we examined NF-κB signaling pathway as 
another candidate pathway for anti-inflammatory effect of 
berberine and we found berberine decreases I-κB phosphorylation. 
Recently, studies on berberine have reported that the anti- 
inflammatory effect of berberine is induced by reducing NF-κB 
signaling pathway in adipocytes, and one of them clarified that 
berberine suppresses IL-1β and TNF-α production through the 
inhibition of I-κB degradation and that result in the inhibition 
of NF-κB translocation (Hu et al., 2008; Lee et al., 2007). If 
the anti-inflammatory effect of berberine is not mediated by 
leptin, NF-κB could be another molecule which is responsible 
for that. Therefore, NF-κB signal transduction seems to be 
responsible for anti-inflammatory effect of berberine. 
Until now, we have investigated the anti-inflammatory effect 
of berberine and its underlying mechanism. We primarily 
considered that berberine has anti-inflammatory effect in 
accordance with its anti-adipogenic effect. So we hypothesized 
that leptin is the molecule that relates two effects of berberine 
on 3T3-L1 adipocytes. However, leptin signaling has not been 88 Leptin and anti-inflammatory effect of berberine
affected by berberine treatment but NF-κB signaling has been 
changed instead. In conclusion, the anti-inflammatory effect of 
berberine is not mediated by anti-adipogenicity but by a different 
mechanism possibly NF-κB pathway.
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